DSGN
Design Therapeutics Inc

385
Mkt Cap
$585.02M
Volume
58.00
52W High
$10.97
52W Low
$2.60
PE Ratio
-8.65
DSGN Fundamentals
Price
$10.27
Prev Close
$9.95
Open
$10.20
50D MA
$9.64
Beta
1.63
Avg. Volume
310,829.80
EPS (Annual)
-$0.8763
P/B
2.93
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Design Therapeutics (NASDAQ:DSGN) Shares Gap Up - Still a Buy?
Design Therapeutics (NASDAQ:DSGN) Shares Gap Up - Still a Buy...
MarketBeat·10d ago
News Placeholder
More News
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Time to Buy?
Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Time to Buy...
MarketBeat·13d ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Given Consensus Rating of "Moderate Buy" by Brokerages
Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·17d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Sets New 52-Week High - Here's What Happened
Design Therapeutics (NASDAQ:DSGN) Sets New 52-Week High - Time to Buy...
MarketBeat·18d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut Design Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·23d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Shares Down 6.5% - Time to Sell?
Design Therapeutics (NASDAQ:DSGN) Shares Down 6.5% - What's Next...
MarketBeat·25d ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Shares Down 10% - What's Next?
Design Therapeutics (NASDAQ:DSGN) Trading Down 10% - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Wall Street Zen Upgrades Design Therapeutics (NASDAQ:DSGN) to "Hold"
Wall Street Zen upgraded shares of Design Therapeutics from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Design Therapeutics (NASDAQ:DSGN) Shares Down 4.5% - What's Next?
Design Therapeutics (NASDAQ:DSGN) Shares Down 4.5% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five ratings firms that are covering the firm, Marketbeat reports...
MarketBeat·1mo ago
<
1
2
...
>

Latest DSGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.